首页> 外文期刊>Vaccine >The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications
【24h】

The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications

机译:猪胃肠病毒相关疾病对现场减毒病毒典型猪瘟疫苗的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Porcine circovirus associated diseases (PCVADs) are among the most important diseases affecting the worldwide swine industry. Vaccination against porcine circovirus type 2 (PCV2) infection has been utilized for disease control and effectively reduces clinical signs of PCVADs. To evaluate the efficacy of the PCV2 vaccine in field farms, we conducted a trial using conventional pigs immunized with the subunit PCV2 vaccine followed by PCV2 challenge. Immunized pigs demonstrated lower serum viral loads, less viral antigen staining in lymph nodes, and higher average daily weight gain, confirming the protective efficacy of the vaccine. However, low levels of PCV2 infection were still detected in vaccinated pigs after challenge, suggesting that the PCV2 vaccine was unable to eradicate the virus, which could lead to asymptomatic PCV2 subclinical infection (PCV2-SI) in pig farms. Additionally, PCV2 infection is a risk factor for impaired pig immune response development during the weaning to growth stages, which is a crucial period to receive vaccines against classical swine fever (CSF). Therefore, the impact of PCV2-SI or PCV2-systemic disease (PCV2-SD) on live attenuated CSF vaccine was investigated. After PCV2 challenge, there was no difference in levels of classical swine fever virus (CSFV) neutralizing antibodies (NA) between pigs with PCV2-SD and PCV2-SI, suggesting that the efficacy of CSF vaccine was compromised. Moreover, results of long-term monitoring of CSFV NA titers in PCV2-SI pigs with minimized interference by maternally-derived antibodies suggested that serum PCV2 viral loads greater than 10(2) copies/mL may compromise the efficacy of CSF vaccine. Overall, a conventional pig model was established to demonstrate the impaired efficacy of the subunit PCV2 vaccine and its impact on the CSF vaccine in vaccination-challenge trials. Additionally, the impaired efficacy of the PCV2 vaccine resulted in increased PCV2-SI, eventually leading to compromised the live attenuated CSF vaccine induced NA response in field farm applications. (C) 2019 Elsevier Ltd. All rights reserved.
机译:猪胃肠病毒相关疾病(PCVADS)是影响全球猪业的最重要的疾病之一。针对猪胃肠病毒2型(PCV2)感染的疫苗接种已被用于疾病控制,从而有效减少PCVAD的临床症状。为了评估PCV2疫苗在野外农场的疗效,我们使用与亚基PCV2疫苗免疫的常规猪进行试验,然后进行PCV2攻击。免疫猪呈下血清病毒载量降低,淋巴结中的病毒抗原染色较低,以及更高的平均每日体重增加,确认疫苗的保护效果。然而,在攻击后仍然在疫苗的猪中检测到低水平的PCV2感染,表明PCV2疫苗无法消除病毒,这可能导致猪场中的无症状PCV2亚临床感染(PCV2-Si)。此外,PCV2感染是对生长阶段的猪免疫反应发育受损的危险因素,这是接受针对古典猪瘟(CSF)疫苗的关键时期。因此,研究了PCV2-Si或PCV2-全身疾病(PCV2-SD)对现场减毒CSF疫苗的影响。在PCV2挑战之后,古典猪瘟病毒(CSFV)中和抗体在PCV2-SD和PCV2-Si之间的中和抗体(Na)没有差异,表明CSF疫苗的功效受到损害。此外,PCV2-Si猪中CSFV Na滴度的长期监测具有最小化的母源性抗体的结果表明,大于10(2)拷贝/ mL的血清PCV2病毒载量可能会损害CSF疫苗的功效。总的来说,建立了传统的猪模型,以证明亚基PCV2疫苗的效果受损及其对接种攻击试验中CSF疫苗的影响。另外,PCV2疫苗的有效性受损导致PCV2-Si增加,最终导致损伤现场减毒的CSF疫苗诱导的现场农场应用中的NA反应。 (c)2019 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号